December 03, 2021
Article
Multiple GBS vaccine candidates are in development, but none are available despite development efforts spanning multiple decades.
November 30, 2021
AzaSite is indicated for the treatment of bacterial conjunctivitis caused by CDC coryneform group G, Haemophilus influenzae, Staphylococcus aureus, Streptococcus mitis group, and Streptococcus pneumoniae.
November 15, 2021
It was previously known that beta-lactam antibiotics function by restricting cell wall growth, but the exact mechanics have remained unknown until now.
November 11, 2021
Study of human lung tissue and airway samples from patients with bacterial pneumonia shows that IL-26 applies modulatory effects on the immune system.
November 09, 2021
This research could help improve the efficacy of antibiotics without clinicians having to attempt risky strategies such as providing patients with higher doses or relying on the discovery of new types of antibiotics, according to the study authors.
November 01, 2021
The study also found that certain E. coli cells in these microenvironments were able to survive phage treatment without acquiring genetic resistance.
October 25, 2021
The immune response of all 15 serotypes in the V114 pneumococcal vaccination were higher than those in the PCV13 vaccination.
October 13, 2021
Video
Musey addressed any gaps and limitations that researchers should be focusing on in future studies and what he hopes to see for the future of pneumococcal vaccines and this disease.
October 08, 2021
Musey discussed the highlights of the new data and how these 2 studies are different than previous studies in this topic area.
October 07, 2021
As the researchers searched for an antibiotic to pair up with the antibacterial bacteriophage, they found that they could treat the infection with the bacteriophage alone.
